病毒安全測試服務市場（按測試類型、應用程式、最終用戶和地區）

Virus Safety Testing Services Market, By Testing Type, By Application, By End User, By Geography

出版日期: 2025年06月10日 | 出版商:

Coherent Market Insights | 英文 157 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

病毒安全檢測服務市場規模預計在 2025 年達到 6.824 億美元，預計到 2032 年將達到 19.875 億美元，2025 年至 2032 年的複合年成長率為年複合成長率%。

分析範圍		分析詳細資訊
基準年	2024	市場規模（2025年）	6.824億美元
效能數據	2020-2024	預測期	2025-2032
預測期內的複合年成長率（2025-2032）	16.50%	預計金額（2032年）	19.875億美元

近年來，由於對確保生物製藥產品安全和品質的需求不斷成長，全球病毒安全檢測服務市場經歷了顯著成長。病毒安全檢測是生物製藥產品生產過程中至關重要的環節，因為它有助於識別和去除可能對病人安全構成威脅的病毒污染物。該市場涵蓋一系列服務，例如病毒清除測試、病毒惰性測試以及病毒檢測和鑑定。由於生物製藥產品日益複雜，且為確保其安全而製定的監管要求日益嚴格，預計對專業病毒安全檢測服務的需求將持續成長。

市場動態：

全球病毒安全檢測服務市場受到多種因素驅動，包括慢性病盛行率的上升、對生物製藥需求的不斷成長、以及確保這些產品安全性和品質的嚴格監管要求。癌症、糖尿病和自體免疫疾病等慢性病盛行率的上升導致對生物製藥的需求增加，推動了病毒安全檢測服務市場的成長。此外，單株抗體和重組蛋白等生物製藥藥物的日益複雜化使得需要專門的檢測服務來確保其安全性和有效性。然而，病毒安全檢測服務成本高昂以及缺乏標準化的檢測通訊協定是限制市場成長的一些因素。儘管有這些挑戰，市場仍提供了巨大的成長機會，尤其是在亞太地區和拉丁美洲等對生物製藥藥物需求旺盛的新興市場。

本報告的主要特點

本報告對全球病毒安全檢測服務市場進行了詳細分析，並以 2024 年為基準年，展示了預測期（2025-2032 年）的市場規模和複合年成長率。
它還強調了每個細分市場的潛在商機，並解釋了該市場的有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素和機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
全球病毒安全檢測服務市場的主要企業是根據公司概況、產品系列、主要亮點、財務績效和策略等參數列出的。
透過本報告的見解，負責人和企業經營團隊可以就未來的產品發布、合作夥伴關係、市場擴張和行銷策略做出明智的決策。
《全球病毒安全檢測服務市場》報告涉及該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過用於分析全球病毒安全檢測服務市場的各種策略矩陣來更輕鬆地做出決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 682.4 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	16.50%	2032 Value Projection:	USD 1,987.5 Mn

The global virus safety testing services market has witnessed significant growth in recent years, driven by the increasing demand for ensuring the safety and quality of biopharmaceutical products. Virus safety testing is a critical aspect of the biopharmaceutical manufacturing process, as it helps to identify and eliminate potential viral contaminants that could pose a threat to patient safety. The market encompasses a range of services, including viral clearance studies, viral inactivation studies, and virus detection and identification. With the growing complexity of biopharmaceutical products and the stringent regulatory requirements for ensuring their safety, the demand for specialized virus safety testing services is expected to continue to rise in the coming years.

Market Dynamics:

The global virus safety testing services market is driven by several factors, including the increasing prevalence of chronic diseases, the growing demand for biopharmaceutical products, and the stringent regulatory requirements for ensuring the safety and quality of these products. The rising incidence of chronic diseases such as cancer, diabetes, and autoimmune disorders has led to an increased demand for biopharmaceutical products, which, in turn, has fueled the growth of the virus safety testing services market. In addition, the increasing complexity of biopharmaceutical products, such as monoclonal antibodies and recombinant proteins, has created a need for specialized testing services to ensure their safety and efficacy. However, the high cost of virus safety testing services and the lack of standardized protocols for testing are some of the factors that could restrain the growth of the market. Despite these challenges, the market offers significant opportunities for growth, particularly in emerging markets such as Asia Pacific and Latin America, where the demand for biopharmaceutical products is increasing rapidly.

Key Features of the Study:

This report provides in-depth analysis of the global virus safety testing services market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global virus safety testing services market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Charles River Laboratories, Lonza Group, Merck KGaA, WuXi AppTec, SGS SA, IDEXX Laboratories, Thermo Fisher Scientific, Eurofins Scientific, Abbot Laboratories, Becton, Dickinson and Company, GenScript Biotech Corporation, Viropro Inc., PPD Inc., and Catalent Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global virus safety testing services market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global virus safety testing services market

Market Segmentation

Testing Type Insights (Revenue, USD Mn, 2020 - 2032)
- Viral Detection Testing
- Viral Clearance Testing
- Adventitious Virus Testing
- Viral Inactivation Services
- Antibody Production Tests
- Retrovirus Tests
- Other Virus Safety Tests
Application Insights (Revenue, USD Mn, 2020 - 2032)
- Vaccines
- Antibodies
- Gene and Cell Therapy
- Blood Product Safety
- Tissue & Tissue-based Products
- Regenerative Medicine
- Other Applications
End User Insights (Revenue, USD Mn, 2020 - 2032)
- Pharmaceutical Companies
- Biopharmaceutical Companies
- Contract Research Organizations (CROs)
- Academic and Research Institutes
- Others
Regional Insights (Revenue, USD Mn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Charles River Laboratories
- Lonza Group
- Merck KGaA
- WuXi AppTec
- SGS SA
- IDEXX Laboratories
- Thermo Fisher Scientific
- Eurofins Scientific
- Abbot Laboratories
- Becton, Dickinson and Company
- GenScript Biotech Corporation
- Viropro Inc.
- PPD Inc.
- Catalent Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Virus Safety Testing Services Market, By Testing Type
- Global Virus Safety Testing Services Market, By Application
- Global Virus Safety Testing Services Market, By End User
- Global Virus Safety Testing Services Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends

4. Global Virus Safety Testing Services Market, By Testing Type, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Viral Detection Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Viral Clearance Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Adventitious Virus Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Viral Inactivation Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Antibody Production Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Retrovirus Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Other Virus Safety Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

5. Global Virus Safety Testing Services Market, By Application, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Gene and Cell Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Blood Product Safety
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Tissue & Tissue-based Products
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Regenerative Medicine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Other Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Virus Safety Testing Services Market, By End User, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Pharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Virus Safety Testing Services Market, By Region, 2020 - 2032, Value (USD Mn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Testing Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Testing Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Testing Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Testing Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Testing Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Testing Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
  - South Africa
  - North Africa
  - Central Africa

8. Competitive Landscape

Charles River Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Lonza Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck KGaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
WuXi AppTec
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
SGS SA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
IDEXX Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Eurofins Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Abbot Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Becton, Dickinson and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GenScript Biotech Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Viropro Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
PPD Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Catalent Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies